prasugrel

FDA Adds Boxed Warning to Plavix Label to Highlight Reduced Effectiveness of the Drug In Poor Metabolizers

March 15, 2010
The U.S. Food and Drug Administration (FDA) has updated the label information for the commonly used anti-clotting medication Plavix ® (clopidogrel) to stress to physicians that patients carrying certain genetic...
Read More

Medco to Include Genetics in Comparison of Anti-Clotting Drug Effectiveness

October 28, 2009
Medco Health Solutions, Inc., announced this week that it will conduct a clinical trial to assess whether clopidogrel bisulfate (Plavix ®, Bristol-Myers Squibb and Sanofi-aventis) is just as effective as...
Read More